Mallinckrodt agreed to pay $100 million and license one of its products to a competitor to wrap up an FTC probe.

​​​​​​​Patients in the U.K. face yet another barrier to access with reports the country is considering drug rationing.

The same way they do to vote for a favorite singer on “The Voice,” consumers can now text Pfizer for a discount on erectile dysfunction drug Viagra.

Allergan officially has its first FDA approval of the year in hand with rosacea treatment Rhofade. But it may have to snag share from laser treatments.

The leadership changes just keep on coming at GlaxoSmithKline. The latest? Global pharma president Abbas Hussain is out, and AstraZeneca vet Luke Miels is in.…

Here’s a radical solution for hepatitis C treatment in the U.S.: The government could buy Gilead Sciences. Price: $156 billion. Payoff: Curing hep C patients…

Pfizer CEO Ian Read says the “ethical” pharma industry he knows is nothing like notorious ex-CEO Martin Shkreli's work, and certainly isn't "…

As the pharma industry comes under renewed attack by President-elect Donald Trump, PhRMA is gearing up for a big-spending ad campaign, with a new theme and…

Drug wholesaler McKesson will pay $150 million to settle with the Justice Department allegations that it did not monitor "suspicious" opioid orders…

Pharma